ObsEva announces the rejection of moratorium procedures
Ad hoc publication based on Art. 53 LR of the Swiss Stock Exchange SIX GENEVA, Switzerland– December 19in 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company that develops and commercializes new therapies for women’s health, announced today that the competent court in Geneva, Switzerland approved the Company’s request to lift the moratorium, …
ObsEva announces the rejection of moratorium procedures Read More »